1-[[4-anilino-6-(1-piperidinyl)-1,3,5-triazin-2-yl]amino]-3-cyclohexylthiourea

1-[[4-Anilino-6-(1-piperidinyl)-1,3,5-triazin-2-yl]amino]-3-cyclohexylthiourea is a complex organic molecule with a rather lengthy and specific chemical name. This compound is a **potential drug candidate** that has been researched for its potential to inhibit the enzyme **dipeptidyl peptidase-IV (DPP-IV)**.

Here's why this compound is important for research:

* **DPP-IV Inhibition:** DPP-IV is a key enzyme involved in the breakdown of incretin hormones, like GLP-1 and GIP. These hormones play a vital role in regulating blood glucose levels by stimulating insulin secretion and suppressing glucagon release.
* **Potential for Diabetes Treatment:** By inhibiting DPP-IV, this compound could potentially increase the levels of incretin hormones in the body, leading to better control of blood glucose levels in individuals with type 2 diabetes. This is because it would allow incretin hormones to be active for a longer period of time, enhancing their beneficial effects.
* **Potential for Other Applications:** DPP-IV inhibitors are also being investigated for their potential therapeutic effects in other conditions such as obesity, cardiovascular disease, and Alzheimer's disease.

**Important Note:** It's crucial to understand that this compound is still under research and development. Extensive preclinical and clinical studies are needed to determine its safety, efficacy, and potential benefits for human health.

**In summary, 1-[[4-Anilino-6-(1-piperidinyl)-1,3,5-triazin-2-yl]amino]-3-cyclohexylthiourea is a potential DPP-IV inhibitor that is being studied for its potential to treat diabetes and other diseases. While the compound holds promise, further research is necessary to confirm its safety and effectiveness.**